A child with a urinary tract infection has 50,000 to 100,000 CFU of a single pathogen and persistent symptoms. Which action is indicated?

A child with a urinary tract infection has 50,000 to 100,000 CFU of a single pathogen and persistent symptoms. Which action is indicated?

• A. CBC and CRP testing
• B. Sensitivity testing before antibiotics
• C. Repeat culture if symptoms persist
• D. Continue antibiotics without adjustment

Answer: (B)

When a child has a urinary tract infection with persistent symptoms and a substantial bacterial load, the priority is to tailor therapy to what the organism is actually susceptible to. That means obtaining a urine culture with antibiotic susceptibility testing before continuing or adjusting treatment. Knowing the exact pathogen and its sensitivities lets you choose an antibiotic that will effectively eradicate the infection, reducing the risk of ongoing symptoms, progression to upper tract infection, or renal complications. Labs like CBC or CRP can reflect inflammation but don’t tell you which antibiotic will work. Repeating a culture alone without susceptibility data won’t guide therapy if the current antibiotic isn’t effective, and continuing the same antibiotic despite resistance risks failure. After you have susceptibility results, you can switch to the most appropriate agent and adjust the course as needed.

When a child has a urinary tract infection with persistent symptoms and a substantial bacterial load, the priority is to tailor therapy to what the organism is actually susceptible to. That means obtaining a urine culture with antibiotic susceptibility testing before continuing or adjusting treatment. Knowing the exact pathogen and its sensitivities lets you choose an antibiotic that will effectively eradicate the infection, reducing the risk of ongoing symptoms, progression to upper tract infection, or renal complications.

Labs like CBC or CRP can reflect inflammation but don’t tell you which antibiotic will work. Repeating a culture alone without susceptibility data won’t guide therapy if the current antibiotic isn’t effective, and continuing the same antibiotic despite resistance risks failure. After you have susceptibility results, you can switch to the most appropriate agent and adjust the course as needed.